A randomized, multicentre, double blind, placebo-controlled trial of anti TNF alpha (adalimumab) in refractory hand osteoarthritis. The Dora study

Complete list of metadatas

https://hal.univ-lorraine.fr/hal-01509629
Contributor : Imopa Ul <>
Submitted on : Tuesday, April 18, 2017 - 11:57:09 AM
Last modification on : Tuesday, February 26, 2019 - 10:12:41 AM

Links full text

Identifiers

Citation

X. Chevalier, P. Ravaud, E. Maheu, G. Baron, A. Rialland, et al.. A randomized, multicentre, double blind, placebo-controlled trial of anti TNF alpha (adalimumab) in refractory hand osteoarthritis. The Dora study. 2013 OARSI World Congress, Apr 2013, Philadelphie, United States. ⟨10.1016/j.joca.2013.02.311⟩. ⟨hal-01509629⟩

Share

Metrics

Record views

77